Test Code MSMN Membranous Nephropathy Target Antigen Identification, Mass Spectrometry, Tissue
Ordering Guidance
This test should be performed on cases with a confirmed diagnosis of membranous nephropathy. Ideally, these cases should already be confirmed as phospholipase A2 receptor (PLA2R) negative, based on PLA2R immunohistochemistry (IHC) or immunofluorescence (IF) testing, not PLA2R serology testing.
If PLA2R IHC or IF testing has not been performed, order test PLAIF / Phospholipase A2 Receptor (PLA2R), Renal Biopsy and submit the additional required specimen.
Additional Testing Requirements
If phospholipase A2 receptor testing using immunohistochemistry or immunofluorescence (IF) has not previously been performed, PLAIF / Phospholipase A2 Receptor (PLA2R), Renal Biopsy must also be ordered and will be charged separately. An additional frozen IF block or frozen unstained slides will be required.
Necessary Information
The following information is required. Testing will not proceed without this information.
1. Preliminary pathology report and clinical history
2. Immunofluorescence (IF) slides (or IF images via external storage device)
3. Electron microscopy (EM) images (via external storage device)
Specimen Required
Specimen Type: Kidney tissue
Supplies: Pathology Packaging Kit (T554)
Container/Tube: Formalin-fixed, paraffin-embedded tissue block
Additional Information: Do not send fixed tissue slides. Testing can only be done on paraffin-embedded tissue blocks.
Secondary ID
620788Useful For
Identification of antigen in membranous nephropathy
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
MSMNT | Mass Spectrometry, MN TC | No, (Bill Only) | No |
MNLCP | Microdissection, Laser Capture, MN | No, (Bill Only) | No |
Testing Algorithm
Requests for this test are reviewed by a Mayo Clinic renal pathologist prior to testing. After review of the submitted pathology report, electron microscopy images, phospholipase A2 receptor (PLA2R) staining results, and paraffin block, testing will proceed. If PLA2R results are not available, the pathologist may contact the ordering healthcare professional for the results or for additional specimen (frozen material/slides) to conduct the studies at Mayo Clinic Laboratories.
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
MN Target Antigen ID, LC MS, TsSpecimen Type
SpecialSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Special | Ambient (preferred) | ||
Refrigerated |
Reject Due To
Fixed tissue slides Wet/frozen tissue Cytological smears Non-formalin fixed tissue Nonparaffin embedded tissue |
Reject |
Reference Values
An interpretive report will be provided.
Day(s) Performed
Monday through Friday
Report Available
7 to 15 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82542
88380
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
MSMN | MN Target Antigen ID, LC MS, Ts | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
620789 | Interpretation | 59465-5 |
620790 | Participated in the Interpretation | No LOINC Needed |
620791 | Report electronically signed by | 19139-5 |
620792 | Material Received | 81178-6 |
620793 | Disclaimer | 62364-5 |
620794 | Case Number | 80398-1 |
620795 | Gross Description | 22634-0 |
620796 | Addendum | 35265-8 |